Skip to main content
SpringerLink
Log in

Neuroblastoma

  • Chapter
  • First Online:
Rickham's Neonatal Surgery

  • 2041 Accesses

Abstract

Neuroblastoma is a common solid tumor of infancy and childhood. It is uniquely characterized by a distinct natural history and prognosis in infants compared with older children. Whereas older children often experience rapidly progressive disease with a poor prognosis, many infants have indolent tumors that may exhibit only minimal progression over time or may even regress entirely. While the prognosis for infants with neuroblastoma is typically optimistic, patients still require multimodal therapy, ideally provided by institutions with expertise in the treatment of pediatric cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Virchow RLK. Die krankhaften Geschwulste; dreissig Vorlesungen, gehalten wahrend des Wintersemesters 1862–1863 an der Universitat zu Berlin. Berlin: Hirschwald; 1863.

    Google Scholar 

  2. Pepper W. A study of congenital sarcoma of the liver and suprarenal. Am J Med Sci. 1901;121:287–99.

    Article  Google Scholar 

  3. D’Angio GJ, Evans AE, Koop CE. Special pattern of widespread neuroblastoma with a favourable prognosis. Lancet. 1971;1:1046–9.

    Article  PubMed  Google Scholar 

  4. Hutchison R. On suprarenal sarcoma in children with metastasis in the skull. Quart J Med. 1907;1:33–41.

    Google Scholar 

  5. Wright JH. Neurocytoma or neuroblastoma, a kind of tumor not generally recognized. J Exp Med. 1910;12:556–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Cushing H, Wolbach SB. The transformation of a malignant paravertebral sympathicoblastoma into a benign ganglioneuroma. Am J Pathol. 1927;3:203–216.7.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Mason GA, Hart-Mercer J, Millar EJ, Strang LB, Wynne NA. Adrenaline-secreting neuroblastoma in an infant. Lancet. 1957;273:322–5.

    Article  CAS  PubMed  Google Scholar 

  8. Brodeur GM, Sekhon G, Goldstein MN. Chromosomal aberrations in human neuroblastomas. Cancer. 1977;40:2256–63.

    Article  CAS  PubMed  Google Scholar 

  9. Schwab M, Alitalo K, Klempnauer KH, Varmus HE, Bishop JM, Gilbert F, Brodeur G, Goldstein M, Trent J. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature. 1983;305:245–8.

    Article  CAS  PubMed  Google Scholar 

  10. Matthay KK, DeSantes K, Hasegawa B, Huberty J, Hattner RS, Ablin A, Reynolds CP, Seeger RC, Weinberg VK, Price D. Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma. J Clin Oncol. 1998;16:229–36.

    Article  CAS  PubMed  Google Scholar 

  11. Kushner BH, Kramer K, Cheung NK. Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma. J Clin Oncol. 2001;19:4189–94.

    Article  CAS  PubMed  Google Scholar 

  12. Li J, Thompson TD, Miller JW, Pollack LA, Stewart SL. Cancer incidence among children and adolescents in the United States, 2001–2003. Pediatrics. 2008;121:e1470–7.

    Article  PubMed  Google Scholar 

  13. Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992–2004). Cancer. 2008;112:416–32.

    Article  PubMed  Google Scholar 

  14. Kenney LB, Miller BA, Ries LA, Nicholson HS, Byrne J, Reaman GH. Increased incidence of cancer in infants in the U.S.: 1980–1990. Cancer. 1998;82:1396–400.

    Article  CAS  PubMed  Google Scholar 

  15. Spix C, Pastore G, Sankila R, Stiller CA, Steliarova-Foucher E. Neuroblastoma incidence and survival in European children (1978–1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42:2081–91.

    Article  PubMed  Google Scholar 

  16. Nickerson HJ, Matthay KK, Seeger RC, Brodeur GM, Shimada H, Perez C, Atkinson JB, Selch M, Gerbing RB, Stram DO, Lukens J. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children’s Cancer Group study. J Clin Oncol. 2000;18:477–86.

    Article  CAS  PubMed  Google Scholar 

  17. Stiller CA, Parkin DM. International variations in the incidence of neuroblastoma. Int J Cancer. 1992;52:538–43.

    Article  CAS  PubMed  Google Scholar 

  18. Tsuchida Y, Ikeda H, Iehara T, Toyoda Y, Kawa K, Fukuzawa M. Neonatal neuroblastoma: incidence and clinical outcome. Med Pediatr Oncol. 2003;40:391–3.

    Article  PubMed  Google Scholar 

  19. MacCarthy A, Bunch KJ, Fear NT, King JC, Vincent TJ, Murphy MFG. Paternal occupation and neuroblastoma: a case-control study based on cancer registry data for Great Britain 1962–1999. Br J Cancer. 2010;102:615–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Moore A, Enquobahrie DA. Paternal occupational exposure to pesticides and risk of neuroblastoma among children: a meta-analysis. Cancer Causes Control. 2011;22:1529–36.

    Article  PubMed  Google Scholar 

  21. Olshan AF, De Roos AJ, Teschke K, Neglia JP, Stram DO, Pollock BH, Castleberry RP. Neuroblastoma and parental occupation. Cancer Causes Control. 1999;10:539–49.

    Article  CAS  PubMed  Google Scholar 

  22. Michalek AM, Buck GM, Nasca PC, Freedman AN, Baptiste MS, Mahoney MC. Gravid health status, medication use, and risk of neuroblastoma. Am J Epidemiol. 1996;143:996–1001.

    Article  CAS  PubMed  Google Scholar 

  23. Kerr MA, Nasca PC, Mundt KA, Michalek AM, Baptiste MS, Mahoney MC. Parental occupational exposures and risk of neuroblastoma: a case-control study (United States). Cancer Causes Control. 2000;11:635–43.

    Article  CAS  PubMed  Google Scholar 

  24. Bunin GR, Ward E, Kramer S, Rhee CA, Meadows AT. Neuroblastoma and parental occupation. Am J Epidemiol. 1990;131:776–80.

    Article  CAS  PubMed  Google Scholar 

  25. Nyari TA, Dickinson HO, Parker L. Childhood cancer in relation to infections in the community during pregnancy and around the time of birth. Int J Cancer. 2003;104:772–7.

    Article  CAS  PubMed  Google Scholar 

  26. Bluhm E, McNeil DE, Cnattingius S, Gridley G, Ghormli El L, Fraumeni JF. Prenatal and perinatal risk factors for neuroblastoma. Int J Cancer. 2008;123:2885–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Johnson KJ, Puumala SE, Soler JT, Spector LG. Perinatal characteristics and risk of neuroblastoma. Int J Cancer. 2008;123:1166–72.

    Article  CAS  PubMed  Google Scholar 

  28. McLaughlin CC, Baptiste MS, Schymura MJ, Zdeb MS, Nasca PC. Perinatal risk factors for neuroblastoma. Cancer Causes Control. 2009;20:289–301.

    Article  PubMed  Google Scholar 

  29. Kushner BH, Gilbert F, Helson L. Familial neuroblastoma. Case reports, literature review, and etiologic considerations. Cancer. 1986;57:1887–93.

    Article  CAS  PubMed  Google Scholar 

  30. Maris JM, Kyemba SM, Rebbeck TR, White PS, Sulman EP, Jensen SJ, Allen C, Biegel JA, Brodeur GM. Molecular genetic analysis of familial neuroblastoma. Eur J Cancer. 1997;33:1923–8.

    Article  CAS  PubMed  Google Scholar 

  31. Knudson AG, Strong LC. Mutation and cancer: neuroblastoma and pheochromocytoma. Am J Hum Genet. 1972;24:514–32.

    PubMed  PubMed Central  Google Scholar 

  32. Friedman DL, Kadan-Lottick NS, Whitton J, Mertens AC, Yasui Y, Liu Y, Meadows AT, Robison LL, Strong LC. Increased risk of cancer among siblings of long-term childhood cancer survivors: a report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev. 2005;14:1922–7.

    Article  PubMed  Google Scholar 

  33. Amiel J, Laudier B, Attié-Bitach T, Trang H, de Pontual L, Gener B, Trochet D, Etchevers H, Ray P, Simonneau M, Vekemans M, Munnich A, Gaultier C, Lyonnet S. Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat Genet. 2003;33:459–61.

    Article  CAS  PubMed  Google Scholar 

  34. Moore SW. The contribution of associated congenital anomalies in understanding Hirschsprung’s disease. Pediatr Surg Int. 2006;22:305–15.

    Article  CAS  PubMed  Google Scholar 

  35. Maris JM, Chatten J, Meadows AT, Biegel JA, Brodeur GM. Familial neuroblastoma: a three-generation pedigree and a further association with Hirschsprung disease. Med Pediatr Oncol. 1997;28:1–5.

    Article  CAS  PubMed  Google Scholar 

  36. Kushner BH, Hajdu SI, Helson L. Synchronous neuroblastoma and von Recklinghausen’s disease: a review of the literature. J Clin Oncol. 1985;3:117–20.

    Article  CAS  PubMed  Google Scholar 

  37. DeBaun MR, Tucker MA. Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry. J Pediatr. 1998;132:398–400.

    Article  CAS  PubMed  Google Scholar 

  38. Knudson AG, Meadows AT. Developmental genetics of neuroblastoma. J Natl Cancer Inst. 1976;57:675–82.

    Article  PubMed  Google Scholar 

  39. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971;68:820–3.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Brodeur GM, Maris JM, Yamashiro DJ, Hogarty MD, White PS. Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol. 1997;19:93–101.

    Article  CAS  PubMed  Google Scholar 

  41. Look AT, Hayes FA, Nitschke R, McWilliams NB, Green AA. Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med. 1984;311:231–5.

    Article  CAS  PubMed  Google Scholar 

  42. Gilbert F, Feder M, Balaban G, Brangman D, Lurie DK, Podolsky R, Rinaldt V, Vinikoor N, Weisband J. Human neuroblastomas and abnormalities of chromosomes 1 and 17. Cancer Res. 1984;44:5444–9.

    CAS  PubMed  Google Scholar 

  43. Savelyeva L, Corvi R, Schwab M. Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells. Am J Hum Genet. 1994;55:334–40.

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Van Roy N, Laureys G, Cheng NC, Willem P, Opdenakker G, Versteeg R, Speleman F. 1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines. Genes Chromosomes Cancer. 1994;10:103–14.

    Article  PubMed  Google Scholar 

  45. Bown N, Cotterill S, Lastowska M, O’Neill S, Pearson AD, Plantaz D, Meddeb M, Danglot G, Brinkschmidt C, Christiansen H, Laureys G, Speleman F, Nicholson J, Bernheim A, Betts DR, Vandesompele J, Van Roy N. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med. 1999;340:1954–61.

    Article  CAS  PubMed  Google Scholar 

  46. Bown N, Lastowska M, Cotterill S, O’Neill S, Ellershaw C, Roberts P, Lewis I, Pearson AD. U.K. Cancer Cytogenetics Group and the U.K. Children’s Cancer Study Group 17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children’s Cancer Study Group. Med Pediatr Oncol. 2001;36:14–9.

    Article  CAS  PubMed  Google Scholar 

  47. Brodeur GM, Green AA, Hayes FA, Williams KJ, Williams DL, Tsiatis AA. Cytogenetic features of human neuroblastomas and cell lines. Cancer Res. 1981;41:4678–86.

    CAS  PubMed  Google Scholar 

  48. Maris JM, White PS, Beltinger CP, Sulman EP, Castleberry RP, Shuster JJ, Look AT, Brodeur GM. Significance of chromosome 1p loss of heterozygosity in neuroblastoma. Cancer Res. 1995;55:4664–9.

    CAS  PubMed  Google Scholar 

  49. White PS, Maris JM, Beltinger C, Sulman E, Marshall HN, Fujimori M, Kaufman BA, Biegel JA, Allen C, Hilliard C. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2–36.3. Proc Natl Acad Sci U S A. 1995;92:5520–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. White PS, Maris JM, Sulman EP, Jensen SJ, Kyemba SM, Beltinger CP, Allen C, Kramer DL, Biegel JA, Brodeur GM. Molecular analysis of the region of distal 1p commonly deleted in neuroblastoma. Eur J Cancer. 1997;33:1957–61.

    Article  CAS  PubMed  Google Scholar 

  51. Maris JM, Guo C, Blake D, White PS, Hogarty MD, Thompson PM, Rajalingam V, Gerbing R, Stram DO, Matthay KK, Seeger RC, Brodeur GM. Comprehensive analysis of chromosome 1p deletions in neuroblastoma. Med Pediatr Oncol. 2001;36:32–6.

    Article  CAS  PubMed  Google Scholar 

  52. Caron H, van Sluis P, de Kraker J, Bökkerink J, Egeler M, Laureys G, Slater R, Westerveld A, Voûte PA, Versteeg R. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med. 1996;334:225–30.

    Article  CAS  PubMed  Google Scholar 

  53. Brinkschmidt C, Poremba C, Christiansen H, Simon R, Schäfer KL, Terpe HJ, Lampert F, Boecker W, Dockhorn-Dworniczak B. Comparative genomic hybridization and telomerase activity analysis identify two biologically different groups of 4s neuroblastomas. Br J Cancer. 1998;77:2223–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Lastowska M, Nacheva E, McGuckin A, Curtis A, Grace C, Pearson A, Bown N. Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children’s Cancer Study Group. Genes Chromosomes Cancer. 1997;18:162–9.

    Article  CAS  PubMed  Google Scholar 

  55. Thompson PM, Seifried BA, Kyemba SK, Jensen SJ, Guo C, Maris JM, Brodeur GM, Stram DO, Seeger RC, Gerbing R, Matthay KK, Matise TC, White PS. Loss of heterozygosity for chromosome 14q in neuroblastoma. Med Pediatr Oncol. 2001;36:28–31.

    Article  CAS  PubMed  Google Scholar 

  56. Attiyeh EF, London WB, Mossé YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK, Maris JM. Children’s Oncology Group Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med. 2005;353:2243–53.

    Article  CAS  PubMed  Google Scholar 

  57. Maris JM, Mossé YP, Bradfield JP, Hou C, Monni S, Scott RH, Asgharzadeh S, Attiyeh EF, Diskin SJ, Laudenslager M, Winter C, Cole KA, Glessner JT, Kim C, Frackelton EC, Casalunovo T, Eckert AW, Capasso M, Rappaport EF, McConville C, London WB, Seeger RC, Rahman N, Devoto M, Grant SFA, Li H, Hakonarson H. Chromosome 6p22 locus associated with clinically aggressive neuroblastoma. N Engl J Med. 2008;358:2585–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Seeger RC, Wada R, Brodeur GM, Moss TJ, Bjork RL, Sousa L, Slamon DJ. Expression of N-myc by neuroblastomas with one or multiple copies of the oncogene. Prog Clin Biol Res. 1988;271:41–9.

    CAS  PubMed  Google Scholar 

  59. Reiter JL, Brodeur GM. MYCN is the only highly expressed gene from the core amplified domain in human neuroblastomas. Genes Chromosomes Cancer. 1998;23:134–40.

    Article  CAS  PubMed  Google Scholar 

  60. Schwab M, Varmus HE, Bishop JM. Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture. Nature. 1985;316:160–2.

    Article  CAS  PubMed  Google Scholar 

  61. Small MB, Hay N, Schwab M, Bishop JM. Neoplastic transformation by the human gene N-myc. Mol Cell Biol. 1987;7:1638–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Weiss WA, Aldape K, Mohapatra G, Feuerstein BG, Bishop JM. Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J. 1997;16:2985–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science. 1984;224:1121–4.

    Article  CAS  PubMed  Google Scholar 

  64. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med. 1985;313:1111–6.

    Article  CAS  PubMed  Google Scholar 

  65. Nakagawara A, Arima M, Azar CG, Scavarda NJ, Brodeur GM. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. Cancer Res. 1992;52:1364–8.

    CAS  PubMed  Google Scholar 

  66. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med. 1993;328:847–54.

    Article  CAS  PubMed  Google Scholar 

  67. Nakagawara A, Azar CG, Scavarda NJ, Brodeur GM. Expression and function of TRK-B and BDNF in human neuroblastomas. Mol Cell Biol. 1994;14:759–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Svensson T, Rydén M, Schilling FH, Dominici C, Sehgal R, Ibáñez CF, Kogner P. Coexpression of mRNA for the full-length neurotrophin receptor trk-C and trk-A in favourable neuroblastoma. Eur J Cancer. 1997;33:2058–63.

    Article  CAS  PubMed  Google Scholar 

  69. Rydén M, Sehgal R, Dominici C, Schilling FH, Ibáñez CF, Kogner P. Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis. Br J Cancer. 1996;74:773–9.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Yamashiro DJ, Liu XG, Lee CP, Nakagawara A, Ikegaki N, McGregor LM, Baylin SB, Brodeur GM. Expression and function of Trk-C in favourable human neuroblastomas. Eur J Cancer. 1997;33:2054–7.

    Article  CAS  PubMed  Google Scholar 

  71. Shimada H, Chatten J, Newton WA, Sachs N, Hamoudi AB, Chiba T, Marsden HB, Misugi K. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst. 1984;73:405–16.

    Article  CAS  PubMed  Google Scholar 

  72. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, Stram DO, Gerbing RB, Lukens JN, Matthay KK, Castleberry RP. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer. 1999;86:364–72.

    Article  CAS  PubMed  Google Scholar 

  73. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer. 1999;86:349–63.

    Article  CAS  PubMed  Google Scholar 

  74. Brodeur GM, Seeger RC, Barrett A, Berthold F, Castleberry RP, D’Angio G, De Bernardi B, Evans AE, Favrot M, Freeman AI. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol. 1988;6:1874–81.

    Article  CAS  PubMed  Google Scholar 

  75. Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol. 1993;11:1466–77.

    Article  CAS  PubMed  Google Scholar 

  76. Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, Kaneko M, London WB, Matthay KK, Nuchtern JG, von Schweinitz D, Simon T, Cohn SL, Pearson ADJ, Task Force INRG. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol. 2009;27:298–303.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Neuroblastoma treatment (PDQ). Bethesda: National Cancer Institute; National Institutes of Health. http://www.cancer.gov/cancertopics/pdq/treatment/neuroblastoma/HealthProfessional/Page3#Section_14. Accessed Feb. 20, 2012.

  78. Cohn SL, Pearson ADJ, London WB, Monclair T, Ambros PF, Brodeur GM, Faldum A, Hero B, Iehara T, Machin D, Mosseri V, Simon T, Garaventa A, Castel V, Matthay KK, Task Force INRG. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol. 2009;27:289–97.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Moppett J, Haddadin I, Foot AB. Neonatal neuroblastoma. Arch Dis Child Fetal Neonatal Ed. 1999;81:F134–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Haas D, Ablin AR, Miller C, Zoger S, Matthay KK. Complete pathologic maturation and regression of stage IVS neuroblastoma without treatment. Cancer. 1988;62:818–25.

    Article  CAS  PubMed  Google Scholar 

  81. Schmidt ML, Lukens JN, Seeger RC, Brodeur GM, Shimada H, Gerbing RB, Stram DO, Perez C, Haase GM, Matthay KK. Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children’s Cancer Group study. J Clin Oncol. 2000;18:1260–8.

    Article  CAS  PubMed  Google Scholar 

  82. De Bernardi B, Gerrard M, Boni L, Rubie H, Cañete A, Di Cataldo A, Castel V, Forjaz de Lacerda A, Ladenstein R, Ruud E, Brichard B, Couturier J, Ellershaw C, Munzer C, Bruzzi P, Michon J, Pearson ADJ. Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification. J Clin Oncol. 2009;27:1034–40.

    Article  PubMed  Google Scholar 

  83. Rubie H, De Bernardi B, Gerrard M, Cañete A, Ladenstein R, Couturier J, Ambros P, Munzer C, Pearson ADJ, Garaventa A, Brock P, Castel V, Valteau-Couanet D, Holmes K, Di Cataldo A, Brichard B, Mosseri V, Marquez C, Plantaz D, Boni L, Michon J. Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1. J Clin Oncol. 2011;29:449–55.

    Article  CAS  PubMed  Google Scholar 

  84. Gigliotti AR, Di Cataldo A, Sorrentino S, Parodi S, Rizzo A, Buffa P, Granata C, Sementa AR, Fagnani AM, Provenzi M, Prete A, D’Ippolito C, Clerico A, Castellano A, Tonini GP, Conte M, Garaventa A, De Bernardi B. Neuroblastoma in the newborn. A study of the Italian Neuroblastoma Registry. Eur J Cancer. 2009;45:3220–7.

    Article  PubMed  Google Scholar 

  85. De Bernardi B, Pianca C, Boni L, Brisigotti M, Carli M, Bagnulo S, Corciulo P, Mancini A, De Laurentis C, Di Tullio MT. Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Outcome related to age and stage. Italian Cooperative Group on Neuroblastoma. Cancer. 1992;70:625–33.

    Article  Google Scholar 

  86. Jennings RW, LaQuaglia MP, Leong K, Hendren WH, Adzick NS. Fetal neuroblastoma: prenatal diagnosis and natural history. J Pediatr Surg. 1993;28:1168–74.

    Article  CAS  PubMed  Google Scholar 

  87. Acharya S, Jayabose S, Kogan SJ, Tugal O, Beneck D, Leslie D, Slim M. Prenatally diagnosed neuroblastoma. Cancer. 1997;80:304–10.

    Article  CAS  PubMed  Google Scholar 

  88. Granata C, Fagnani AM, Gambini C, Boglino C, Bagnulo S, Cecchetto G, Federici S, Inserra A, Michelazzi A, Riccipetitoni G, Rizzo A, Tamaro P, Jasonni V, De Bernardi B. Features and outcome of neuroblastoma detected before birth. J Pediatr Surg. 2000;35:88–91.

    Article  CAS  PubMed  Google Scholar 

  89. Nuchtern JG. Perinatal neuroblastoma. Semin Pediatr Surg. 2006;15:10–6.

    Article  PubMed  Google Scholar 

  90. Adams GA, Shochat SJ, Smith EI, Shuster JJ, Joshi VV, Altshuler G, Hayes FA, Nitschke R, McWilliams N, Castleberry RP. Thoracic neuroblastoma: a Pediatric Oncology Group study. J Pediatr Surg. 1993;28:372–7. discussion 377–8

    Article  CAS  PubMed  Google Scholar 

  91. Abramson SJ, Berdon WE, Ruzal-Shapiro C, Stolar C, Garvin J. Cervical neuroblastoma in eleven infants—a tumor with favorable prognosis. Clinical and radiologic (US, CT, MRI) findings. Pediatr Radiol. 1993;23:253–7.

    Article  CAS  PubMed  Google Scholar 

  92. Haase GM, O’Leary MC, Stram DO, Lukens JN, Seeger RC, Shimada H, Matthay KK. Pelvic neuroblastoma—implications for a new favorable subgroup: a Children’s Cancer Group experience. Ann Surg Oncol. 1995;2:516–23.

    Article  CAS  PubMed  Google Scholar 

  93. Nitschke R, Smith EI, Shochat S, Altshuler G, Travers H, Shuster JJ, Hayes FA, Patterson R, McWilliams N. Localized neuroblastoma treated by surgery: a Pediatric Oncology Group Study. J Clin Oncol. 1988;6:1271–9.

    Article  CAS  PubMed  Google Scholar 

  94. Perez CA, Matthay KK, Atkinson JB, Seeger RC, Shimada H, Haase GM, Stram DO, Gerbing RB, Lukens JN. Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a Children’s Cancer Group study. J Clin Oncol. 2000;18:18–26.

    Article  CAS  PubMed  Google Scholar 

  95. De Bernardi B, Conte M, Mancini A, Donfrancesco A, Alvisi P, Tomà P, Casale F, Cordero di Montezemolo L, Cornelli PE, Carli M. Localized resectable neuroblastoma: results of the second study of the Italian Cooperative Group for Neuroblastoma. J Clin Oncol. 1995;13:884–93.

    Article  PubMed  Google Scholar 

  96. La Quaglia MP, Kushner BH, Su W, Heller G, Kramer K, Abramson S, Rosen N, Wolden S, Cheung NKV. The impact of gross total resection on local control and survival in high-risk neuroblastoma. J Pediatr Surg. 2004;39:412–7.

    Article  PubMed  Google Scholar 

  97. O’Neill JA, Littman P, Blitzer P, Soper K, Chatten J, Shimada H. The role of surgery in localized neuroblastoma. J Pediatr Surg. 1985;20:708–12.

    Article  PubMed  Google Scholar 

  98. Haase GM, Wong KY, deLorimier AA, Sather HN, Hammond GD. Improvement in survival after excision of primary tumor in stage III neuroblastoma. J Pediatr Surg. 1989;24:194–200.

    Article  CAS  PubMed  Google Scholar 

  99. Shorter NA, Davidoff AM, Evans AE, Ross AJ, Zeigler MM, O’Neill JA. The role of surgery in the management of stage IV neuroblastoma: a single institution study. Med Pediatr Oncol. 1995;24:287–91.

    Article  CAS  PubMed  Google Scholar 

  100. Le Tourneau JN, Bernard JL, Hendren WH, Carcassonne M. Evaluation of the role of surgery in 130 patients with neuroblastoma. J Pediatr Surg. 1985;20:244–9.

    Article  PubMed  Google Scholar 

  101. Castel V, Tovar JA, Costa E, Cuadros J, Ruiz A, Rollan V, Ruiz-Jimenez JI, Perez-Hernández R, Cañete A. The role of surgery in stage IV neuroblastoma. J Pediatr Surg. 2002;37:1574–8.

    Article  PubMed  Google Scholar 

  102. Kaneko M, Iwakawa M, Ikebukuro K, Ohkawa H. Complete resection is not required in patients with neuroblastoma under 1 year of age. J Pediatr Surg. 1998;33:1690–4.

    Article  CAS  PubMed  Google Scholar 

  103. Guglielmi M, De Bernardi B, Rizzo A, Federici S, Boglino C, Siracusa F, Leggio A, Cozzi F, Cecchetto G, Musi L, Bardini T, Fagnani AM, Bartoli GC, Pampaloni A, Rogers D, Conte M, Milanaccio C, Bruzzi P. Resection of primary tumor at diagnosis in stage IV-S neuroblastoma: does it affect the clinical course? J Clin Oncol. 1996;14:1537–44.

    Article  CAS  PubMed  Google Scholar 

  104. Shamberger RC, Smith EI, Joshi VV, Rao PV, Hayes FA, Bowman LC, Castleberry RP. The risk of nephrectomy during local control in abdominal neuroblastoma. J Pediatr Surg. 1998;33:161–4.

    Article  CAS  PubMed  Google Scholar 

  105. Adkins ES, Sawin R, Gerbing RB, London WB, Matthay KK, Haase GM. Efficacy of complete resection for high-risk neuroblastoma: a Children’s Cancer Group study. J Pediatr Surg. 2004;39(6):931.

    Article  PubMed  Google Scholar 

  106. Rich BS, McEvoy MP, Kelly NE, Oh E, Abramson SJ, Price AP, Cheung NKV, La Quaglia MP. Resectability and operative morbidity after chemotherapy in neuroblastoma patients with encasement of major visceral arteries. J Pediatr Surg. 2011;46:103–7.

    Article  PubMed  Google Scholar 

  107. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, Gerbing RB, Reynolds CP. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children’s Cancer Group. N Engl J Med. 1999;341:1165–73.

    Article  CAS  PubMed  Google Scholar 

  108. Matthay KK, Reynolds CP, Seeger RC, Shimada H, Adkins ES, Haas-Kogan D, Gerbing RB, London WB, Villablanca JG. Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a Children’s Oncology Group study. J Clin Oncol. 2009;27:1007–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Kushner BH, Kramer K, LaQuaglia MP, Modak S, Yataghene K, Cheung NKV. Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma. J Clin Oncol. 2004;22:4888–92.

    Article  CAS  PubMed  Google Scholar 

  110. Kushner BH, Kramer K, LaQuaglia MP, Modak S, Cheung NKV. Liver involvement in neuroblastoma: the Memorial Sloan-Kettering Experience supports treatment reduction in young patients. Pediatr Blood Cancer. 2006;46:278–84.

    Article  PubMed  Google Scholar 

  111. Baker DL, Schmidt ML, Cohn SL, Maris JM, London WB, Buxton A, Stram D, Castleberry RP, Shimada H, Sandler A, Shamberger RC, Look AT, Reynolds CP, Seeger RC, Matthay KK. Children’s Oncology Group Outcome after reduced chemotherapy for intermediate-risk neuroblastoma. N Engl J Med. 2010;363:1313–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  112. Rich BS, McEvoy MP, LaQuaglia MP, Wolden SL. Local control, survival, and operative morbidity and mortality after re-resection, and intraoperative radiation therapy for recurrent or persistent primary high-risk neuroblastoma. J Pediatr Surg. 2011;46:97–102.

    Article  PubMed  Google Scholar 

  113. Gillis AM, Sutton E, Dewitt KD, Matthay KK, Weinberg V, Fisch BM, Chan A, Gooding C, Daldrup-Link H, Wara WM, Farmer DL, Harrison MR, Haas-Kogan D. Long-term outcome and toxicities of intraoperative radiotherapy for high-risk neuroblastoma. Int J Radiat Oncol Biol Phys. 2007;69:858–64.

    Article  PubMed  Google Scholar 

  114. Kunieda E, Hirobe S, Kaneko T, Nagaoka T, Kamagata S, Nishimura G. Patterns of local recurrence after intraoperative radiotherapy for advanced neuroblastoma. Jpn J Clin Oncol. 2008;38:562–6.

    Article  PubMed  Google Scholar 

  115. Yu AL, Gilman AL, Ozkaynak MF, London WB, Kreissman SG, Chen HX, Smith M, Anderson B, Villablanca JG, Matthay KK, Shimada H, Grupp SA, Seeger R, Reynolds CP, Buxton A, Reisfeld RA, Gillies SD, Cohn SL, Maris JM, Sondel PM. Children’s Oncology Group Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med. 2010;363:1324–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  116. Yamamoto K, Ohta S, Ito E, Hayashi Y, Asami T, Mabuchi O, Higashigawa M, Tanimura M. Marginal decrease in mortality and marked increase in incidence as a result of neuroblastoma screening at 6 months of age: cohort study in seven prefectures in Japan. J Clin Oncol. 2002;20:1209–14.

    Article  PubMed  Google Scholar 

  117. Woods WG, Gao RN, Shuster JJ, Robison LL, Bernstein M, Weitzman S, Bunin G, Levy I, Brossard J, Dougherty G, Tuchman M, Lemieux B. Screening of infants and mortality due to neuroblastoma. N Engl J Med. 2002;346:1041–6.

    Article  PubMed  Google Scholar 

  118. Schilling FH, Spix C, Berthold F, Erttmann R, Fehse N, Hero B, Klein G, Sander J, Schwarz K, Treuner J, Zorn U, Michaelis J. Neuroblastoma screening at one year of age. N Engl J Med. 2002;346:1047–53.

    Article  PubMed  Google Scholar 

  119. Laverdière C, Liu Q, Yasui Y, Nathan PC, Gurney JG, Stovall M, Diller LR, Cheung NK, Wolden S, Robison LL, Sklar CA. Long-term outcomes in survivors of neuroblastoma: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2009;101:1131–40.

    Article  PubMed  PubMed Central  Google Scholar 

  120. Levitt GA, Platt KA, De Byrne R, Sebire N, Owens CM. 4S neuroblastoma: the long-term outcome. Pediatr Blood Cancer. 2004;43:120–5.

    Article  CAS  PubMed  Google Scholar 

  121. Laverdière C, Cheung NKV, Kushner BH, Kramer K, Modak S, LaQuaglia MP, Wolden S, Ness KK, Gurney JG, Sklar CA. Long-term complications in survivors of advanced stage neuroblastoma. Pediatr Blood Cancer. 2005;45:324–32.

    Article  PubMed  Google Scholar 

  122. Kushner BH. Neuroblastoma: a disease requiring a multitude of imaging studies. J Nucl Med. 2004;45:1172–88.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA

    Joshua N. Honeyman MD & Michael P. La Quaglia MD

Authors
  1. Joshua N. Honeyman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael P. La Quaglia MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael P. La Quaglia MD .

Editor information

Editors and Affiliations

  1. Division of Child Health, Alder Hey Children’s NHS Foundation Trust, Liverpool, United Kingdom

    Paul D. Losty

  2. University of Pennsylvania , Philadelphia, Pennsylvania, USA

    Alan W. Flake

  3. Childrens Hospital, University of Helsinki, Helsinki, Finland

    Risto J. Rintala

  4. Royal Children’s Hospital, University of Melbourne, Parkville, Victoria, Australia

    John M. Hutson

  5. Department of Surgery, Meiji University of Integrative Medicine, Kyoto, Japan

    Naomi lwai

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag London Ltd., part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Honeyman, J.N., La Quaglia, M.P. (2018). Neuroblastoma. In: Losty, P., Flake, A., Rintala, R., Hutson, J., lwai, N. (eds) Rickham's Neonatal Surgery. Springer, London. https://doi.org/10.1007/978-1-4471-4721-3_57

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4721-3_57

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4720-6

  • Online ISBN: 978-1-4471-4721-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation